Literature DB >> 7999348

Behavioral treatment of depression in patients with dementia.

L Teri1.   

Abstract

This article provides an overview of the theory, clinical application, and research data on behavioral treatment of depression in dementia patients. Behavioral theory of depression in nondemented adults indicates that decreased positive person-environment interactions initiate and maintain a cycle of depression that may be amenable to treatment. This same cycle is discussed as it appears in demented adults, and treatment is suggested. This treatment focuses on altering the aversive events and interactions that maintain patient depression, by increasing pleasant events and interactions, maximizing cognitive abilities, and teaching caregivers strategies for behavior change and effective problem solving. A 9-week clinical research protocol is provided with specific session-by-session content. Preliminary data are presented from a controlled clinical trial of this approach. Results thus far indicate that behavioral treatment is effective in reducing depression in patients with Alzheimer disease and in reducing the level of depression in their caregivers. The implications of these findings on future clinical care of patients and research directions are discussed.

Entities:  

Mesh:

Year:  1994        PMID: 7999348

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  8 in total

1.  The effects of a multimodal intervention on outcomes of persons with early-stage dementia.

Authors:  Sandy C Burgener; Yang Yang; Ruth Gilbert; Sara Marsh-Yant
Journal:  Am J Alzheimers Dis Other Demen       Date:  2008-05-04       Impact factor: 2.035

2.  Is sertraline treatment or depression remission in depressed Alzheimer patients associated with improved caregiver well being? Depression in Alzheimer's Disease Study 2.

Authors:  Crystal V Flynn Longmire; Lea T Drye; Constantine E Frangakis; Barbara K Martin; Curtis L Meinert; Jacobo E Mintzer; Cynthia A Munro; Anton P Porsteinsson; Peter V Rabins; Paul B Rosenberg; Lon S Schneider; Daniel Weintraub; Constantine G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2014-01       Impact factor: 4.105

Review 3.  Psychosocial interventions for late-life major depression: evidence-based treatments, predictors of treatment outcomes, and moderators of treatment effects.

Authors:  Dimitris N Kiosses; Andrew C Leon; Patricia A Areán
Journal:  Psychiatr Clin North Am       Date:  2011-06

4.  Living well with stroke: design and methods for a randomized controlled trial of a psychosocial behavioral intervention for poststroke depression.

Authors:  Pamela H Mitchell; Linda Teri; Richard Veith; Ann Buzaitis; David Tirschwell; Kyra Becker; Michael Fruin; Ruth Kohen; Kevin C Cain
Journal:  J Stroke Cerebrovasc Dis       Date:  2008 May-Jun       Impact factor: 2.136

5.  Staff training in assisted living: evaluating treatment fidelity.

Authors:  Linda Teri; Glenise L McKenzie; Kenneth C Pike; Carol J Farran; Cornelia Beck; Olimpia Paun; David LaFazia
Journal:  Am J Geriatr Psychiatry       Date:  2010-06       Impact factor: 4.105

6.  Staff Reports of Behavioral Expressions of Persons With Dementia in 250 Assisted Living Communities.

Authors:  Debra Dobbs; Sheryl Zimmerman; Paula Carder; Anna S Beeber; Stephanie J Palmertree
Journal:  Gerontologist       Date:  2022-02-09

7.  Quality of life of residents with dementia in long-term care settings in the Netherlands and Belgium: design of a longitudinal comparative study in traditional nursing homes and small-scale living facilities.

Authors:  Alida Hpm de Rooij; Katrien G Luijkx; Anja G Declercq; Jos Mga Schols
Journal:  BMC Geriatr       Date:  2011-05-03       Impact factor: 3.921

8.  Anxiety and depression symptoms among caregivers of care-recipients with subjective cognitive decline and cognitive impairment.

Authors:  Xiaoniu Liang; Qihao Guo; Jianfeng Luo; Fang Li; Ding Ding; Qianhua Zhao; Zhen Hong
Journal:  BMC Neurol       Date:  2016-10-03       Impact factor: 2.474

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.